Portfolio Holdings Detail for ISIN IE0003WV2ME7
Stock Name / Fund iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF Ticker ISPE(GBP) LSE
ETF Ticker ISPE.L(GBP) LSE

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-18 (Thursday)	115,518	USD 8,611,867	USD 8,611,867	138	USD -64,709	USD 74.55	USD 75.2
2025-09-17 (Wednesday)	115,380	USD 8,676,576	USD 8,676,576	0	USD 12,692	USD 75.2	USD 75.09
2025-09-16 (Tuesday)	115,380	USD 8,663,884	USD 8,663,884	0	USD -110,765	USD 75.09	USD 76.05
2025-09-15 (Monday)	115,380	USD 8,774,649	USD 8,774,649	0	USD -175,378	USD 76.05	USD 77.57
2025-09-12 (Friday)	115,380	USD 8,950,027	USD 8,950,027
2025-09-10 (Wednesday)	115,380	USD 9,031,946	USD 9,031,946
2025-09-09 (Tuesday)	115,448	USD 9,212,750	USD 9,212,750

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE0003WV2ME7

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 BUY 138 74.550* 73.15
2025-08-18 BUY 126 78.300* 73.09
2025-08-12 SELL -68 76.930* 72.99 Profit of 4,963 on sale
2025-07-29 BUY 73 80.470* 72.87
2025-07-23 SELL -204 76.910* 72.80 Profit of 14,851 on sale
2025-07-22 SELL -408 76.300* 72.78 Profit of 29,695 on sale
2025-07-21 SELL -136 76.560* 72.76 Profit of 9,895 on sale
2025-07-15 SELL -136 76.810* 72.72 Profit of 9,890 on sale
2025-07-14 SELL -340 78.280* 72.69 Profit of 24,714 on sale
2025-07-11 SELL -204 78.050* 72.66 Profit of 14,822 on sale
2025-07-10 SELL -816 78.800* 72.62 Profit of 59,259 on sale
2025-07-09 SELL -272 77.190* 72.60 Profit of 19,746 on sale
2025-07-08 SELL -884 76.390* 72.57 Profit of 64,155 on sale
2025-07-03 SELL -1,156 76.790* 72.50 Profit of 83,809 on sale
2025-07-02 SELL -209 77.020* 72.47 Profit of 15,147 on sale
2025-06-27 SELL -3,332 78.210* 72.40 Profit of 241,250 on sale
2025-06-25 BUY 68 76.970* 72.35
2025-06-24 SELL -2,516 75.850* 72.33 Profit of 181,973 on sale
2025-06-23 SELL -68 75.320* 72.31 Profit of 4,917 on sale
2025-06-20 SELL -6,454 73.830* 72.30 Profit of 466,615 on sale
2025-06-18 SELL -432 73.980* 72.28 Profit of 31,224 on sale
2025-06-17 SELL -792 73.270* 72.27 Profit of 57,239 on sale
2025-06-11 SELL -216 75.470* 72.23 Profit of 15,601 on sale
2025-06-10 SELL -504 75.800* 72.20 Profit of 36,391 on sale
2025-06-06 SELL -144 77.520* 72.14 Profit of 10,389 on sale
2025-06-05 SELL -1,224 77.770* 72.11 Profit of 88,259 on sale
2025-06-02 SELL -5,832 78.100* 71.99 Profit of 419,852 on sale
2025-05-30 SELL -1,296 78.220* 71.95 Profit of 93,246 on sale
2025-05-29 SELL -144 77.730* 71.91 Profit of 10,355 on sale
2025-05-27 SELL -144 76.220* 71.85 Profit of 10,346 on sale
2025-05-23 SELL -216 74.990* 71.80 Profit of 15,510 on sale
2025-05-16 SELL -1,080 78.000* 71.62 Profit of 77,349 on sale
2025-05-15 SELL -216 76.880* 71.58 Profit of 15,462 on sale
2025-05-13 SELL -72 75.500* 71.51 Profit of 5,149 on sale
2025-05-12 SELL -504 74.800* 71.49 Profit of 36,031 on sale
2025-05-09 SELL -432 73.680* 71.47 Profit of 30,877 on sale
2025-05-08 SELL -2,088 74.630* 71.45 Profit of 149,187 on sale
2025-05-07 SELL -144 75.040* 71.42 Profit of 10,285 on sale
2025-05-06 BUY 48 74.920* 71.40
2025-05-01 BUY 2,736 75.180* 71.30
2025-04-30 BUY 1,512 75.490* 71.27
2025-04-29 SELL -288 76.280* 71.23 Profit of 20,515 on sale
2025-04-28 SELL -360 75.540* 71.20 Profit of 25,631 on sale
2025-04-25 BUY 144 76.040* 71.16
2025-04-24 SELL -72 75.130* 71.13 Profit of 5,121 on sale
2025-04-22 SELL -9,648 70.600* 71.14 Profit of 686,316 on sale
2025-04-17 SELL -4,392 71.530* 71.15 Profit of 312,470 on sale
2025-04-16 BUY 144 71.200* 71.14
2025-04-15 BUY 144 70.760* 71.15
2025-04-10 SELL -4,536 68.260* 71.20 Profit of 322,965 on sale
2025-04-09 BUY 360 69.900* 71.21
2025-04-08 BUY 72 67.070* 71.25
2025-04-07 BUY 1,296 69.000* 71.27
2025-04-04 BUY 792 69.360* 71.29
2025-04-02 BUY 504 72.050* 71.28
2025-04-01 BUY 5,610 71.870* 71.27
2025-03-31 BUY 3,989 72.480* 71.26
2025-03-25 BUY 70 71.240* 71.27
2025-03-20 BUY 138 70.950* 71.28
2025-03-18 BUY 345 70.340* 71.29
2025-03-17 BUY 39 70.630* 71.30
2025-03-14 SELL -35 69.290* 71.32 Profit of 2,496 on sale
2025-03-13 SELL -4,595 67.950* 71.36 Profit of 327,888 on sale
2025-03-12 BUY 828 68.510* 71.39
2025-03-11 BUY 828 68.390* 71.42
2025-03-07 BUY 276 70.330* 71.47
2025-03-06 BUY 966 71.800* 71.46
2025-03-05 BUY 5,244 72.850* 71.45
2025-03-04 BUY 276 71.380* 71.45
2025-03-03 BUY 345 71.390* 71.45
2025-02-28 BUY 710 71.620* 71.44
2025-02-27 BUY 639 71.400* 71.45
2025-02-26 SELL -370 71.960* 71.44 Profit of 26,433 on sale
2025-02-25 SELL -71 71.450* 71.44 Profit of 5,072 on sale
2025-02-24 BUY 71 72.760* 71.42
2025-02-20 SELL -923 74.710* 71.36 Profit of 65,863 on sale
2025-02-19 BUY 284 74.670* 71.31
2025-02-18 BUY 290 75.670* 71.26
2025-02-13 BUY 8,094 76.000* 71.06
2025-02-12 BUY 2,414 75.820* 71.00
2025-02-11 BUY 1,993 70.910* 71.00
2025-02-07 BUY 213 70.350* 71.00
2025-02-06 BUY 2,840 70.990* 71.01
2025-02-05 BUY 1,420 72.100* 70.99
2025-02-04 BUY 1,065 71.330* 70.98
2025-02-03 SELL -6,177 71.380* 70.98 Profit of 438,430 on sale
2025-01-31 BUY 568 72.450* 70.96
2025-01-30 BUY 71 73.220* 70.92
2025-01-29 BUY 1,207 71.130* 70.92
2025-01-28 BUY 426 72.560* 70.89
2025-01-27 BUY 426 69.200* 70.92
2025-01-24 BUY 426 68.990* 70.95
2025-01-23 BUY 1,207 68.930* 70.98
2025-01-22 BUY 710 69.040* 71.02
2025-01-21 BUY 4,189 69.970* 71.04
2025-01-17 BUY 852 69.780* 71.08
2025-01-15 BUY 426 70.280* 71.12
2025-01-13 BUY 1,207 71.090* 71.12
2025-01-10 BUY 922 73.420* 71.08
2024-12-31 BUY 213 74.030* 70.85
2024-12-30 BUY 284 74.240* 70.77
2024-12-27 BUY 1,363 75.650* 70.66
2024-12-23 BUY 426 74.810* 70.31
2024-12-20 SELL -2,323 74.810* 70.20 Profit of 163,079 on sale
2024-12-19 BUY 876 73.930* 70.11
2024-12-17 BUY 661 74.120* 69.92
2024-12-16 BUY 219 73.910* 69.81
2024-12-13 BUY 365 73.320* 69.71
2024-12-11 BUY 219 73.810* 69.59
2024-12-10 BUY 146 73.390* 69.48
2024-12-09 BUY 146 70.900* 69.43
2024-12-05 SELL -438 72.430* 69.26 Profit of 30,338 on sale
2024-12-04 BUY 74 74.200* 69.09
2024-12-02 BUY 292 70.530* 69.00
2024-11-29 BUY 1,296 71.350* 68.91
2024-11-27 BUY 288 72.070* 68.65
2024-11-26 BUY 720 71.550* 68.52
2024-11-25 BUY 8,928 71.270* 68.39
2024-11-22 BUY 216 70.480* 68.30
2024-11-21 BUY 216 70.380* 68.19
2024-11-20 BUY 936 69.540* 68.12
2024-11-19 SELL -936 70.200* 68.00 Profit of 63,652 on sale
2024-11-18 BUY 4,320 69.890* 67.89
2024-11-12 BUY 864 65.810* 68.02
2024-11-11 BUY 216 66.700* 68.11
2024-11-08 BUY 868 66.230* 68.25
2024-11-07 BUY 1,464 65.840* 68.43
2024-11-06 BUY 648 65.750* 68.66
2024-11-05 BUY 144 66.690* 68.83
2024-11-04 BUY 745 66.470* 69.07
2024-11-01 BUY 360 67.540* 69.24
2024-10-30 BUY 216 68.630* 69.65
2024-10-29 BUY 1,368 69.370* 69.69
2024-10-25 BUY 288 69.380* 70.06
2024-10-24 BUY 216 70.350* 69.97
2024-10-22 BUY 432 69.240* 70.05
2024-10-21 BUY 360 70.050* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	BUY	138	74.550*	73.15
2025-08-18	BUY	126	78.300*	73.09
2025-08-12	SELL	-68	76.930*	72.99 Profit of 4,963 on sale
2025-07-29	BUY	73	80.470*	72.87
2025-07-23	SELL	-204	76.910*	72.80 Profit of 14,851 on sale
2025-07-22	SELL	-408	76.300*	72.78 Profit of 29,695 on sale
2025-07-21	SELL	-136	76.560*	72.76 Profit of 9,895 on sale
2025-07-15	SELL	-136	76.810*	72.72 Profit of 9,890 on sale
2025-07-14	SELL	-340	78.280*	72.69 Profit of 24,714 on sale
2025-07-11	SELL	-204	78.050*	72.66 Profit of 14,822 on sale
2025-07-10	SELL	-816	78.800*	72.62 Profit of 59,259 on sale
2025-07-09	SELL	-272	77.190*	72.60 Profit of 19,746 on sale
2025-07-08	SELL	-884	76.390*	72.57 Profit of 64,155 on sale
2025-07-03	SELL	-1,156	76.790*	72.50 Profit of 83,809 on sale
2025-07-02	SELL	-209	77.020*	72.47 Profit of 15,147 on sale
2025-06-27	SELL	-3,332	78.210*	72.40 Profit of 241,250 on sale
2025-06-25	BUY	68	76.970*	72.35
2025-06-24	SELL	-2,516	75.850*	72.33 Profit of 181,973 on sale
2025-06-23	SELL	-68	75.320*	72.31 Profit of 4,917 on sale
2025-06-20	SELL	-6,454	73.830*	72.30 Profit of 466,615 on sale
2025-06-18	SELL	-432	73.980*	72.28 Profit of 31,224 on sale
2025-06-17	SELL	-792	73.270*	72.27 Profit of 57,239 on sale
2025-06-11	SELL	-216	75.470*	72.23 Profit of 15,601 on sale
2025-06-10	SELL	-504	75.800*	72.20 Profit of 36,391 on sale
2025-06-06	SELL	-144	77.520*	72.14 Profit of 10,389 on sale
2025-06-05	SELL	-1,224	77.770*	72.11 Profit of 88,259 on sale
2025-06-02	SELL	-5,832	78.100*	71.99 Profit of 419,852 on sale
2025-05-30	SELL	-1,296	78.220*	71.95 Profit of 93,246 on sale
2025-05-29	SELL	-144	77.730*	71.91 Profit of 10,355 on sale
2025-05-27	SELL	-144	76.220*	71.85 Profit of 10,346 on sale
2025-05-23	SELL	-216	74.990*	71.80 Profit of 15,510 on sale
2025-05-16	SELL	-1,080	78.000*	71.62 Profit of 77,349 on sale
2025-05-15	SELL	-216	76.880*	71.58 Profit of 15,462 on sale
2025-05-13	SELL	-72	75.500*	71.51 Profit of 5,149 on sale
2025-05-12	SELL	-504	74.800*	71.49 Profit of 36,031 on sale
2025-05-09	SELL	-432	73.680*	71.47 Profit of 30,877 on sale
2025-05-08	SELL	-2,088	74.630*	71.45 Profit of 149,187 on sale
2025-05-07	SELL	-144	75.040*	71.42 Profit of 10,285 on sale
2025-05-06	BUY	48	74.920*	71.40
2025-05-01	BUY	2,736	75.180*	71.30
2025-04-30	BUY	1,512	75.490*	71.27
2025-04-29	SELL	-288	76.280*	71.23 Profit of 20,515 on sale
2025-04-28	SELL	-360	75.540*	71.20 Profit of 25,631 on sale
2025-04-25	BUY	144	76.040*	71.16
2025-04-24	SELL	-72	75.130*	71.13 Profit of 5,121 on sale
2025-04-22	SELL	-9,648	70.600*	71.14 Profit of 686,316 on sale
2025-04-17	SELL	-4,392	71.530*	71.15 Profit of 312,470 on sale
2025-04-16	BUY	144	71.200*	71.14
2025-04-15	BUY	144	70.760*	71.15
2025-04-10	SELL	-4,536	68.260*	71.20 Profit of 322,965 on sale
2025-04-09	BUY	360	69.900*	71.21
2025-04-08	BUY	72	67.070*	71.25
2025-04-07	BUY	1,296	69.000*	71.27
2025-04-04	BUY	792	69.360*	71.29
2025-04-02	BUY	504	72.050*	71.28
2025-04-01	BUY	5,610	71.870*	71.27
2025-03-31	BUY	3,989	72.480*	71.26
2025-03-25	BUY	70	71.240*	71.27
2025-03-20	BUY	138	70.950*	71.28
2025-03-18	BUY	345	70.340*	71.29
2025-03-17	BUY	39	70.630*	71.30
2025-03-14	SELL	-35	69.290*	71.32 Profit of 2,496 on sale
2025-03-13	SELL	-4,595	67.950*	71.36 Profit of 327,888 on sale
2025-03-12	BUY	828	68.510*	71.39
2025-03-11	BUY	828	68.390*	71.42
2025-03-07	BUY	276	70.330*	71.47
2025-03-06	BUY	966	71.800*	71.46
2025-03-05	BUY	5,244	72.850*	71.45
2025-03-04	BUY	276	71.380*	71.45
2025-03-03	BUY	345	71.390*	71.45
2025-02-28	BUY	710	71.620*	71.44
2025-02-27	BUY	639	71.400*	71.45
2025-02-26	SELL	-370	71.960*	71.44 Profit of 26,433 on sale
2025-02-25	SELL	-71	71.450*	71.44 Profit of 5,072 on sale
2025-02-24	BUY	71	72.760*	71.42
2025-02-20	SELL	-923	74.710*	71.36 Profit of 65,863 on sale
2025-02-19	BUY	284	74.670*	71.31
2025-02-18	BUY	290	75.670*	71.26
2025-02-13	BUY	8,094	76.000*	71.06
2025-02-12	BUY	2,414	75.820*	71.00
2025-02-11	BUY	1,993	70.910*	71.00
2025-02-07	BUY	213	70.350*	71.00
2025-02-06	BUY	2,840	70.990*	71.01
2025-02-05	BUY	1,420	72.100*	70.99
2025-02-04	BUY	1,065	71.330*	70.98
2025-02-03	SELL	-6,177	71.380*	70.98 Profit of 438,430 on sale
2025-01-31	BUY	568	72.450*	70.96
2025-01-30	BUY	71	73.220*	70.92
2025-01-29	BUY	1,207	71.130*	70.92
2025-01-28	BUY	426	72.560*	70.89
2025-01-27	BUY	426	69.200*	70.92
2025-01-24	BUY	426	68.990*	70.95
2025-01-23	BUY	1,207	68.930*	70.98
2025-01-22	BUY	710	69.040*	71.02
2025-01-21	BUY	4,189	69.970*	71.04
2025-01-17	BUY	852	69.780*	71.08
2025-01-15	BUY	426	70.280*	71.12
2025-01-13	BUY	1,207	71.090*	71.12
2025-01-10	BUY	922	73.420*	71.08
2024-12-31	BUY	213	74.030*	70.85
2024-12-30	BUY	284	74.240*	70.77
2024-12-27	BUY	1,363	75.650*	70.66
2024-12-23	BUY	426	74.810*	70.31
2024-12-20	SELL	-2,323	74.810*	70.20 Profit of 163,079 on sale
2024-12-19	BUY	876	73.930*	70.11
2024-12-17	BUY	661	74.120*	69.92
2024-12-16	BUY	219	73.910*	69.81
2024-12-13	BUY	365	73.320*	69.71
2024-12-11	BUY	219	73.810*	69.59
2024-12-10	BUY	146	73.390*	69.48
2024-12-09	BUY	146	70.900*	69.43
2024-12-05	SELL	-438	72.430*	69.26 Profit of 30,338 on sale
2024-12-04	BUY	74	74.200*	69.09
2024-12-02	BUY	292	70.530*	69.00
2024-11-29	BUY	1,296	71.350*	68.91
2024-11-27	BUY	288	72.070*	68.65
2024-11-26	BUY	720	71.550*	68.52
2024-11-25	BUY	8,928	71.270*	68.39
2024-11-22	BUY	216	70.480*	68.30
2024-11-21	BUY	216	70.380*	68.19
2024-11-20	BUY	936	69.540*	68.12
2024-11-19	SELL	-936	70.200*	68.00 Profit of 63,652 on sale
2024-11-18	BUY	4,320	69.890*	67.89
2024-11-12	BUY	864	65.810*	68.02
2024-11-11	BUY	216	66.700*	68.11
2024-11-08	BUY	868	66.230*	68.25
2024-11-07	BUY	1,464	65.840*	68.43
2024-11-06	BUY	648	65.750*	68.66
2024-11-05	BUY	144	66.690*	68.83
2024-11-04	BUY	745	66.470*	69.07
2024-11-01	BUY	360	67.540*	69.24
2024-10-30	BUY	216	68.630*	69.65
2024-10-29	BUY	1,368	69.370*	69.69
2024-10-25	BUY	288	69.380*	70.06
2024-10-24	BUY	216	70.350*	69.97
2024-10-22	BUY	432	69.240*	70.05
2024-10-21	BUY	360	70.050*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares III Public Limited Company
Entity Type
Entity LEI	549300PZLRJB7M8H1057
ETF Ticker	ISPE(GBP) LSE
ETF Ticker	ISPE.L(GBP) LSE